A Comparison of Two Treatment Regimens of Ceftriaxone in Late Lyme Disease
This 2005 prospective, open-label, randomized, multicenter trial compared 14-day versus 28-day intravenous ceftriaxone regimens in 143 serologically confirmed patients with late Lyme disease. Clinical cure rates were 76% for the 14-day group and 70% for the 28-day group (p = NS). While there were more treatment failures in the 14-day
June 26, 2025
No Comments